title_organisation_en

This version is for browsers with a low level of support for CSS, and is des

Biotechnology and Life Sciences in Baden-Württemberg

Logo state of Baden-Württemberg

Home Language Selection


Home Content Area

Home Navigator

You are here:

End Navigator



Health

teaser_img
© DKFZ
Science

teaser_img
© University of Konstanz

Andreas Marx - “Chemical Biology” of DNA polymerases

Whether inside the cell or in molecular biology laboratories, the synthesis of DNA would not be possible without DNA polymerases. The regulation and application of this versatile enzyme family is the subject of research carried out by Prof. Dr. Andreas Marx at the University of Konstanz in Southern Germany. In addition to basic research, Marx deals with the development of novel polymerases that can be used to solve biological issues and also can be used in the molecular diagnosis of diseases.
more

Dossier

Addiction: new concepts for resolving old problems

teaser_img
© www.drogenbeauftragte.de
Addictive substances and behaviours are as varied as their effects on an addict’s health and personality. However, modern neurobiological research has revealed common principles in the development and continuation of addiction, which can be used as an approach for new prevention and therapy strategies including the prevention of relapses. This dossier presents some of the latest research results in the field.
more

Funding I

Bio-based Industries: first Call for Proposals

teaser_img
EU and industry leaders have launched a new European Joint Undertaking on Bio-based Industries (BBI). The aim is to trigger investments and create a competitive market for bio-based products and materials sourced locally and "Made in Europe". Here Europe's untapped biomass and wastes shoud be identified, to develop an emerging bioeconomy sector. Submission deadline for proposals is October 15th, 2014.
more
Funding II

IMI 2: Disease modifying therapy of Type 1 Diabetes Mellitus

teaser_img
Type 1 diabetes mellitus (T1DM) is a chronic disease affecting worldwide around 17 million people. The overall aim of the initiative is to significantly progress the understanding of T1DM disease by bringing together patients, health authorities, leading clinicians, and researchers from the areas of immunology, beta cell biology, and biomarker research from both academia and industry. The deadline for submitting proposals is November 12th, 2014.
more

SEARCH


DATABASE

for Companies and Research Institutions



NEWSLETTER


GLOSSARY

All biological terms with explanation




http://www.cluster-biopolymere.de/index.html?lang=en